Bulletin of the Korean Chemical Society

  • 제29권8호
  • /
  • Pages.1605-1608
  • /
  • 2008
  • /
  • 0253-2964(pISSN)
  • /
  • 1229-5949(eISSN)
대한화학회 (Korean Chemical Society)
권호 표지
DOI QR코드

DOI QR Code

2,6-Dithienyl-4-arylpyridines: Synthesis, Topoisomerase I and II Inhibition and Structure-activity Relationship

  • 발행 : 2008.08.20
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

키워드

참고문헌

  1. Wang, J. C. Annu. Rev. Biochem. 1996, 65, 635 https://doi.org/10.1146/annurev.bi.65.070196.003223
  2. Pommier, Y. Biochimie 1998, 80, 255 https://doi.org/10.1016/S0300-9084(98)80008-4
  3. Redinbo, M. R.; Stewart, L.; Kuhn, P.; Champoux, J. J.; Hol, W. G. Science 1998, 279, 504
  4. Chen, A. Y.; Liu, L. F. Annu. Rev. Pharmacol. Toxicol. 1994, 34, 191 https://doi.org/10.1146/annurev.pa.34.040194.001203
  5. Kellner, U.; Rudolph, P.; Parwaresch, R. Onkologie 2000, 23, 424 https://doi.org/10.1159/000027205
  6. Singh, S. K.; Ruchelman, A. L.; Li, T. K.; Liu, A.; Liu, L. F.; Lavoie, E. J. J. Med. Chem. 2003, 46, 2254 https://doi.org/10.1021/jm020498a
  7. Mukkala, V. M.; Helenius, M.; Hemmila, I.; Kankare, J.; Takalo, H. Helv. Chim. Acta 1993, 76, 1361 https://doi.org/10.1002/hlca.19930760323
  8. Mukkala, V. M.; Kwiatkowski, M.; Kankare, J.; Takalo, H. Helv. Chim. Acta 1993, 76, 893 https://doi.org/10.1002/hlca.19930760213
  9. Lowe, G.; Droz, A. S.; Park, J. J.; Weaver, G. W. Bioorg. Chemistry 1999, 27, 477 https://doi.org/10.1006/bioo.1999.1152
  10. Jennette, K.; Lippard, S. J.; Vassiliades, G.; Bauer, W. Proc. Natl. Acad. Sci. U.S.A. 1974, 71, 3839 https://doi.org/10.1073/pnas.71.10.3839
  11. Liu, H. Q.; Cheung, T. C.; Peng, S. M.; Che, C. M. J. Chem. Soc., Chem. Commun. 1995, 1787
  12. McCoubrey, A.; Latham, H. C.; Cook, P. R.; Rodger, A.; Lower, G. FEBS Letters 1996, 380, 73 https://doi.org/10.1016/0014-5793(95)01537-X
  13. Vliet, P. M. V.; Toekimin, M. S.; Haasnoot, J. G.; Reedijk, J.; Nováková, O.; Vrána, O.; Brabec, V. Inorg. Chim. Acta 1995, 231, 57 https://doi.org/10.1016/0020-1693(94)04320-U
  14. Carter, P. J.; Cheng, C. C.; Thorp, H. H. J. Am. Chem. Soc. 1998, 120, 632 https://doi.org/10.1021/ja9729589
  15. Lowe, G.; Droz, A. S.; Vilaivan, T.; Weaver, G. W.; Tweedale, L.; Pratt, J. M.; Rock, P.; Yardley, V.; Croft, S. L. J. Med. Chem. 1999, 42, 999 https://doi.org/10.1021/jm981074c
  16. Kim, D. S. H. L.; Ashendel, C. L.; Zhou, Q.; Chang, C.-T.; Lee, E. S.; Chang, C.-J. Bioorg. Med. Chem. Lett. 1998, 8, 2695 https://doi.org/10.1016/S0960-894X(98)00468-5
  17. Xu, W. C.; Zhou, Q.; Ashendel, C. L.; Chang, C.-T.; Chang, C.-J. Bioorg. Med. Chem. Lett. 1999, 9, 2279 https://doi.org/10.1016/S0960-894X(99)00375-3
  18. Zhao, L. X.; Kim, T. S.; Ahn, S. H.; Kim, T. H.; Kim, E.-k.; Cho, W. J.; Choi, H.; Lee, C. S.; Kim, J. A.; Jeong, T. C.; Chang, C.-j.; Lee, E. S. Bioorg. Med. Chem. Lett. 2001, 11, 2659 https://doi.org/10.1016/S0960-894X(01)00531-5
  19. Zhao, L.-X.; Moon, Y. S.; Basnet, A.; Kim, E.-K.; Cho, W.-J.; Jahng, Y.; Park, J. G.; Jeong, T. C.; Cho, W. J.; Choi, S. U.; Lee, C. O.; Lee, S. Y.; Lee, C. S.; Lee, E.-S. Bioorg. Med. Chem. Lett. 2004, 14, 1333 https://doi.org/10.1016/j.bmcl.2003.11.084
  20. Zhao, L.-X.; Sherchan, J.; Park, J. K.; Jahng, Y.; Jeong, B.-S.; Jeong, T. C.; Lee, C. S.; Lee, E. S. Arch. Pharm. Res. 2006, 29, 1091 https://doi.org/10.1007/BF02969297
  21. Basnet, A.; Thapa, P.; Karki, R.; Na, Y.; Jahng, Y.; Jeong, B.-S.; Jeong, T. C.; Lee, C. S.; Lee, E. S. Bioorg. Med. Chem. 2007, 15, 4351 https://doi.org/10.1016/j.bmc.2007.04.047
  22. Son, J. K.; Zhao, L. X.; Basnet, A.; Thapa, P.; Karki, R.; Na, Y.; Jahng, Y.; Jeong, T. C.; Jeong, B.-S.; Lee, C. S.; Lee, E. S. Eur. J. Med. Chem. 2008, 43, 675 https://doi.org/10.1016/j.ejmech.2007.05.002
  23. Fukuda, M.; Nishio, K.; Kanzawa, F.; Ogasawara, H.; Ishida, T.; Arioka, H.; Bojanowski, K.; Oka, M.; Saijo, N. Cancer Res. 1996, 56, 789
  24. Zecher, W.; Kröhnke, F. Chem. Ber. 1961, 94 690 https://doi.org/10.1002/cber.19610940317
  25. Zecher, W.; Kröhnke, F. Chem. Ber. 1961, 94, 698 https://doi.org/10.1002/cber.19610940318
  26. Zecher, W.; Kröhnke, F. Chem. Ber. 1961, 94, 707 https://doi.org/10.1002/cber.19610940319
  27. Krohnke, F. Angew. Chem. Int. Ed. 1963, 2, 380 https://doi.org/10.1002/anie.196303801
  28. Kröhnke, F. Synthesis 1976, 1

피인용 문헌

  1. Synthesis of 2,4,6-Tripyridyl Pyridines, and Evaluation of Their Antitumor Cytotoxicity, Topoisomerase I and II Inhibitory Activity, and Structure-activity Relationship vol.32, pp.10, 2011, https://doi.org/10.5012/bkcs.2011.32.10.3566
  2. 2,4-Diaryl-5,6-dihydro-1,10-phenanthrolines with Furyl or Thienyl Moiety at 4-Position: Synthesis, Topoisomerase I and II Inhibitory Activity, and Cytotoxicity vol.33, pp.5, 2012, https://doi.org/10.5012/bkcs.2012.33.5.1769
  3. 2,4-Diaryl-5H-chromeno [4,3-b]pyridines: Synthesis, Topoisomerase I and II Inhibitory Activity, and Cytotoxicity vol.33, pp.9, 2012, https://doi.org/10.5012/bkcs.2012.33.9.3103
  4. Synthetic Utility of Pyridinium Bromide: Synthesis and Antimicrobial Activity of Novel 2,4,6-Trisubstituted Pyridines Having Pyrazole Moiety vol.54, pp.3, 2017, https://doi.org/10.1002/jhet.2790
  5. Iron-Catalyzed Aerobic Oxidative Cleavage and Construction of C−N Bonds: A Facile Method for Synthesis of 2,4,6-Trisubstituted Pyridines vol.7, pp.9, 2018, https://doi.org/10.1002/ajoc.201800312
  6. Synthesis of some new Pyridine-based Heterocyclic Compounds with Anticipated Antitumor Activity vol.55, pp.7, 2018, https://doi.org/10.1002/jhet.3210
  7. ChemInform Abstract: 2,6-Dithienyl-4-arylpyridines: Synthesis, Topoisomerase I and II Inhibition and Structure-Activity Relationship. vol.40, pp.6, 2009, https://doi.org/10.1002/chin.200906159
  8. Design, Synthesis, Antitumor Activity and Mode of Action of Novel Oxiranyl and Thiiranyl Phenol Derivatives vol.30, pp.7, 2008, https://doi.org/10.5012/bkcs.2009.30.7.1463
  9. 2,6-Dithienyl-4-furyl pyridines: Synthesis, topoisomerase I and II inhibition, cytotoxicity, structure–activity relationship, and docking study vol.20, pp.1, 2010, https://doi.org/10.1016/j.bmcl.2009.11.041
  10. Synthesis, Topoisomerase I and II Inhibitory Activities, and Cytotoxicity of 4,6-Diaryl-2,4'-bipyridine Derivatives vol.31, pp.6, 2008, https://doi.org/10.5012/bkcs.2010.31.6.1747
  11. Synthesis, Topoisomerase I and II Inhibitory Activity, Cytotoxicity, and Structure-activity Relationship Study of Rigid Analogues of 2,4,6-Trisubstituted Pyridine Containing 5,6-Dihydrobenzo[h]quinoli vol.32, pp.1, 2008, https://doi.org/10.5012/bkcs.2011.32.1.303
  12. Synthesis of 2,4-diaryl chromenopyridines and evaluation of their topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship vol.46, pp.8, 2008, https://doi.org/10.1016/j.ejmech.2011.04.029
  13. Design, synthesis, and antitumor evaluation of 2,4,6-triaryl pyridines containing chlorophenyl and phenolic moiety vol.52, pp.None, 2008, https://doi.org/10.1016/j.ejmech.2012.03.010
  14. 2,4-Diaryl Benzofuro[3,2-b]pyridine Derivatives: Design, Synthesis, and Evaluation of Topoisomerase Inhibitory Activity and Cytotoxicity vol.34, pp.10, 2008, https://doi.org/10.5012/bkcs.2013.34.10.3073
  15. Discovery of dihydroxylated 2,4-diphenyl-6-thiophen-2-yl-pyridine as a non-intercalative DNA-binding topoisomerase II-specific catalytic inhibitor vol.80, pp.None, 2014, https://doi.org/10.1016/j.ejmech.2014.04.066
  16. Pyridine Derivatives as Biologically Active Precursors; Organics and Selected Coordination Complexes vol.6, pp.13, 2008, https://doi.org/10.1002/slct.202100332